Human breast-carcinoma cells show correlation in expression of C-myc oncogene and the C-myc binding-protein (mbp-1).

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International Journal of Oncology

• Publication date

  1994-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.5.6.1433PMID 21559732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterogeneity of c-myc expression in histologically similar infiltrating ductal carcinomas of the breast

  2005cited by this paper
• A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

  1994cited by this paper
• Isolation and characterization of a cDNA clone showing C-myc binding-activity.

  1994cited by this paper
• Apoptosis in Burkitt lymphoma cells is driven by c-myc.

  1993cited by this paper
• Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation

  1993cited by this paper
• The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.

  1993cited by this paper
• Induction of apoptosis in fibroblasts by c-myc protein.

  1992cited by this paper
• Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors.

  1992cited by this paper
• MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination.

  1992cited by this paper
• Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas.

  1992cited by this paper
• myc function and regulation.

  1992cited by this paper
• Max: functional domains and interaction with c-Myc.

  1992cited by this paper
• Alterations in Copy Number of c‐erbB‐2 and c‐myc Proto‐oncogenes in Advanced Stage of Human Breast Cancer

  1991cited by this paper
• Cloning and characterization of a human c-myc promoter-binding protein

  1991cited by this paper
• Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

  1991cited by this paper
• Evaluation of c-myc proto-oncogene in primary human breast carcinomas.

  1991cited by this paper
• Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer.

  1991cited by this paper
• Sequence-specific DNA binding by Myc proteins.

  1991cited by this paper
• Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation.

  1991cited by this paper
• c-myc oncoprotein function.

  1991cited by this paper
• A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.

  1990cited by this paper
• Sequence-specific DNA binding by the c-Myc protein.

  1990cited by this paper
• Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.

  1989cited by this paper
• Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

  1989cited by this paper
• Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.

  1989cited by this paper
• E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor.

  1989cited by this paper
• A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor

  1989cited by this paper
• High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.

  1989cited by this paper
• c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells

  1988cited by this paper
• Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

  1988cited by this paper
• An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation

  1988cited by this paper
• Transcriptional control of the endogenous MYC protooncogene by antisense RNA.

  1987cited by this paper
• The myc oncogene: its role in transformation and differentiation.

  1986cited by this paper
• Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment

  1986cited by this paper
• In vivo differentiation of blast-phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes.

  1985cited by this paper
• Organization and expression of eucaryotic split genes coding for proteins.

  1981cited by this paper
• The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

  1976cited by this paper

• HIF-1α and MBP1 are associated with the progression of breast cancer cells by repressing β-catenin transcription

  2022cites this paper
• Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer

  2015cites this paper
• Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.

  2014cites this paper
• WITHDRAWN: Modulation of TLR3, TLR4 and TLR7 mediated IFN-β, Rantes and TNFα production by HIVEP1.

  2014cites this paper
• MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2.

  2009cites this paper
• The c-myc promoter: still MysterY and challenge.

  2008cites this paper
• Knockdown of MBP-1 in Human Prostate Cancer Cells Delays Cell Cycle Progression*

  2006cites this paper
• Tumors in Nude Mice Encoding a c-myc Promoter-binding Protein ( MBP-1 ) Inhibits Human Breast Carcinoma Cells Transfected with the Gene

  2006cites this paper
• c-myc Promoter-binding Protein 1 (MBP-1) Regulates Prostate Cancer Cell Growth by Inhibiting MAPK Pathway*

  2005cites this paper
• A Novel 16-Kilodalton Cellular Protein Physically Interacts with and Antagonizes the Functional Activity of c-myc Promoter-Binding Protein 1

  2001cites this paper
• Mutational activation of c-Ha-ras oncogene or cancer promotion by phenobarbital upregulates the transcription of c-jun and c-myc oncogene in N-nitrosodiethylamine-mediated hepatocarcinogenesis

  1999cites this paper
• Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.

  1999cites this paper
• Functional Domains of c-myc Promoter Binding Protein 1 Involved in Transcriptional Repression and Cell Growth Regulation

  1999cites this paper
• MBP-1 physically associates with histone deacetylase for transcriptional repression.

  1999cites this paper
• Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity.

  1997cites this paper
• Chromosomal localization of the human gene encoding c-myc promoter-binding protein (MPB1) to chromosome 1p35-pter.

  1997cites this paper
• Inhibition of human immunodeficiency virus type 1 replication by a cellular transcriptional factor MBP‐1

  1997cites this paper
• Differential expression of c-jun and c-myc in N-nitroso diethylamine-induced hepatic oncogenesis in AKR mice.

  1996cites this paper
• Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice.

  1995cites this paper
• Experimental Therapeutics, Molecular Targets, and Chemical Biology Mbp-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice Comparative Medicine And

  year unknowncites this paper